AbbVie Inc. said its second-quarter earnings rose as strong global sales of the drug maker's rheumatoid-arthritis drug Humira continued to boost results.
Similar Stories to Humira Sales Lift Abbvie Profit on Bing News
WSJ.com: What's News US, Wall Street Journal: Home US
Fri, 07/25/2014 - 5:44am
BING NEWS:
- Healthy Returns: Sales of Humira are plunging, but AbbVie has two promising successors
Share this link with them to sign up. Good morning! Sales of AbbVie's Humira are plummeting as the once-top-selling drug fights competition from cheaper biosimilars in the U.S. and abroad.
04/30/2024 - 1:00 pm | View Link - AbbVie Outlook: Why Humira Biosimilars Won't Undo Huge Sales
Fears that Humira biosimilars will erode AbbVie's topline are overblown, an analyst said Monday. He has an outperform rating on AbbVie stock.
04/29/2024 - 9:07 am | View Link - Drugmaker AbbVie expects Humira volume erosion to worsen
Its shares were down nearly 5% in afternoon trade on Friday, after the company forecast U.S. Humira sales would fall 32% in the second quarter. AbbVie's investors have been closely watching the ...
04/26/2024 - 10:12 am | View Link - AbbVie Q1 report beats Street despite plunging Humira sales
AbbVie said that net revenue from its immunology medications slid 4% over the prior year to $5.37B, due largely to a 36% drop in sales of its top-selling product, Humira, which has been facing ...
04/26/2024 - 5:20 am | View Link - AbbVie raises annual profit forecast on strong Skyrizi sales
AbbVie raised its annual profit forecast on Friday after strong sales of its immunology drug Skyrizi and cancer drug Imbruvica helped the company beat Wall Street estimates for the first quarter. The ...
04/26/2024 - 1:06 am | View Link - More
Welcome to Wopular
Wopular is an
online newspaper rack,
giving you a summary view of the top headlines from the top news sites.
Senh Duong (Founder)
Wopular,
MWB,
RottenTomatoes
MoviesWithButter : Our Sister Site
- "Expendables 4" Starts Shooting This Fall, Says Randy Couture at the Arnold Sports Festival more
- “Expendables 4” Gets Funding Interest from “Ip Man 3” Financier more
- "Ip Man 3" Distributor Suspected of Box Office Fraud, Parent Company Loses $200M in Market Cap more
- Yen Targets "Ip Man 4" for 2018 Release; Discusses Film with Director, Producer more
- "Ip Man 3" Shatters Expectations with $72M Opening [China Box Office] more